Skip to main content

Table 3 Association between different status of sarcopenia, and RAGE in gender difference using linear regression analysis

From: Elevated level of the soluble receptor for advanced glycation end-products involved in sarcopenia: an observational study

Gender

Variables

RAGE

Crude β coefficients

(95% CI)

P Value

Adjusted β coefficients

(95% CI)

P Value

All

Probable

−95.63 (− 343.44, 152.18)

0.448

−76.05 (−333.16, 181.06)

0.561

Confirmed

436.93 (222.05, 651.82)

< 0.001

449.72 (229.39, 670.05)

< 0.001

Severe

94.77 (− 173.60, 363.14)

0.488

154.42 (− 132.99, 441.84)

0.291

Male

Probable

−266.70 (− 844.50, 311.11)

0.363

− 284.20 (− 866.80, 298.41)

0.336

Confirmed

263.85 (−150.26, 677.95)

0.210

154.92 (−291.92, 601.77)

0.494

Severe

62.51 (−280.07, 405.08)

0.719

−52.99 (− 434.77, 328.79)

0.784

Female

Probable

−75.45 (− 365.88, 214.97)

0.609

20.07 (− 276.95, 317.09)

0.894

Confirmed

478.78 (215.11, 742.45)

< 0.001

498.61 (238.77, 758.45)

< 0.001

Severe

142.14 (− 281.71, 565.99)

0.509

320.55 (− 113.07, 754.17)

0.146

  1. aAdjusted covariates: age, sex, smoking, comorbidities (hypertension, diabetes mellitus, myocardial infarction, angina, coronary artery disease, and chronic obstructive pulmonary disease)